FDA Approves New Treatment Option for Patients with ALS

[FDA]

The FDA approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.


Baca selengkapnya di : http://www.fda.gov...